These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 18337324)

  • 21. Yellow fever: epidemiology and prevention.
    Barnett ED
    Clin Infect Dis; 2007 Mar; 44(6):850-6. PubMed ID: 17304460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prophylaxis of communicable diseases in points of entry under the International Health Regulations (2005)].
    Kicman-Gawłowska A
    Przegl Epidemiol; 2008; 62(4):751-8. PubMed ID: 19209737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [International Health Regulations (2005)].
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(4):191-235. PubMed ID: 19856858
    [No Abstract]   [Full Text] [Related]  

  • 25. [International health regulations--evaluation and trends].
    Vessereau A
    World Health Stat Q; 1988; 41(1):37-45. PubMed ID: 3376488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Yellow fever].
    Wiercińska-Drapało A
    Przegl Epidemiol; 2004; 58 Suppl 1():101-5. PubMed ID: 15807166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yellow fever vaccine-associated viscerotropic disease and death in Spain.
    Doblas A; Domingo C; Bae HG; Bohórquez CL; de Ory F; Niedrig M; Mora D; Carrasco FJ; Tenorio A
    J Clin Virol; 2006 Jun; 36(2):156-8. PubMed ID: 16597510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The revised international health regulations and restraint of national health measures.
    von Tigerstrom B
    Health Law J; 2005; 13():35-76. PubMed ID: 17044322
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of yellow fever vaccination practice in England.
    Bryant N; Tucker R; Simons H; Bailey S; Mathewson J; Lea G; Hill DR
    J Travel Med; 2008; 15(5):287-93. PubMed ID: 19006500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global governance, international health law and WHO: looking towards the future.
    Taylor AL
    Bull World Health Organ; 2002; 80(12):975-80. PubMed ID: 12571727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.
    Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM
    Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revision of the International Health Regulations.
    Epidemiol Bull; 1998 Sep; 19(3):14-6. PubMed ID: 9863271
    [No Abstract]   [Full Text] [Related]  

  • 34. WHO regulations to prevent spread of infectious disease.
    Bagchi S
    CMAJ; 2007 Aug; 177(5):447-8. PubMed ID: 17724318
    [No Abstract]   [Full Text] [Related]  

  • 35. CDC Travelers’ Health Branch releases free, web-based training course Yellow Fever: Information for Health Care Professionals Advising Travelers.
    Sommers T; Gershman M
    Clin Infect Dis; 2011 Sep; 53(5):vi-vii. PubMed ID: 21969945
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute viscerotropic disease following vaccination against yellow fever.
    Hayes EB
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):967-71. PubMed ID: 17669451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yellow fever: an emerging threat for Kenya and other east African countries.
    Sanders EJ; Tukei PM
    East Afr Med J; 1996 Jan; 73(1):10-2. PubMed ID: 8625854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yellow fever vaccination: is one dose always enough?
    Patel D; Simons H
    Travel Med Infect Dis; 2013; 11(5):266-73. PubMed ID: 24074827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using the power of the World Health Organization: the international health regulations and the future of international health law.
    Forrest M
    Spec Law Dig Health Care Law; 2001 Sep; (269):9-35. PubMed ID: 11588888
    [No Abstract]   [Full Text] [Related]  

  • 40. Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.
    Vannice K; Wilder-Smith A; Hombach J
    N Engl J Med; 2018 Aug; 379(7):603-605. PubMed ID: 29995585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.